Hospira
Hospira specializes in the development, manufacturing, distribution, and marketing of injectable drugs and infusion technologies worldwide. Its portfolio includes specialty injectable pharmaceuticals like Precedex, Retacrit, Nivestim, Inflectra, along with medication management products such as infusion pumps and software systems. Additionally, Hospira offers intravenous solutions, nutritional products, and contract manufacturing services.
Top Stages
2 past transactions
BresaGen
Acquisition in 2006
BresaGen is a developer of proteins and peptides, especially biogenerics. In October 2006, BresaGen was sold to Hospira Inc of the US, and Paragon made a 2.35x return on investment, and 135% IRR. Hospira acquired the company to further develop BresaGen’s intellectual property, and to distribute its products in the US.
Physiometrix
Acquisition in 2005
Physiometrix is a medical device firm that manufactures non-invasive medical products for use in anesthesia. The company was founded in 1990 and is headquartered in Billerica, Massachusetts, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.